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Abstract
 
Transcription factors of the nuclear factor (NF)-
 
 
 
B/Rel family translocate into the nucleus
upon degradation of the I
 
 
 
Bs. Postinduction repression of NF-
 
 
 
B activity depends on NF-
 
 
 
B–
regulated resynthesis of I
 
 
 
B
 
 
 
, which dissociates NF-
 
 
 
B from DNA and exports it to the cytosol.
We found that after activation, p65/RelA is degraded by the proteasome in the nucleus and in
a DNA binding–dependent manner. If proteasome activity is blocked, NF-
 
 
 
B is not promptly
removed from some target genes in spite of I
 
 
 
B
 
  
 
resynthesis and sustained transcription occurs.
These results indicate that proteasomal degradation of p65/RelA does not merely regulate its
stability and abundance, but also actively promotes transcriptional termination.
Key words: NF-
 
 
 
B • Rel family • proteasome • transcriptional regulation
 
Introduction
 
Transcriptional induction of a large number of inflammatory
genes, immune response genes, and genes promoting cell
survival of both normal and cancer cells is regulated by the
five transcription factors (TFs) of the nuclear factor (NF)-
 
 
 
B/
Rel family, namely p65/RelA, cRel, RelB, p50, and p52
(1–3). Most homodimers and heterodimers generated by
the NF-
 
 
 
B/Rel proteins are found in the cytoplasm of un-
stimulated cells in complexes with three major inhibitory
proteins collectively indicated as I
 
 
 
B, namely I
 
 
 
B
 
 
 
, I
 
 
 
B
 
 
 
,
and I
 
 
 
B
 
  
 
(4). p105 and p100 (the proteins from which p50
and p52 are generated through limited proteasomal pro-
cessing) also contribute to cytoplasmic retention of NF-
 
 
 
B/
Rel dimers. I
 
 
 
Bs contain an NH
 
2
 
-terminal regulatory region
that is phosphorylated in response to stimulation and
COOH-terminal ankyrin repeats that mediate association
with NF-
 
 
 
B dimers. When extracellular signals transduced
from several receptors activate the I
 
 
 
B kinase complex, it
phosphorylates the I
 
 
 
Bs at two amino-terminal serines,
thus targeting them for polyubiquitination by the 
 
 
 
TrCP
proteins and subsequent proteasomal degradation (5). I
 
 
 
B
degradation allows NF-
 
 
 
B to enter the nucleus and bind
target genes. In vitro, the complex between NF-
 
 
 
B and
the 
 
 
 
B site is extremely stable, with a dissociation constant
below 10
 
 
 
11 
 
M (6) and a half-life of 
 
 
 
45 min. This stable
complex can be rapidly dissociated by the addition of
I
 
 
 
B
 
 
 
, which reduces its half-life to 3 min (7). Several
pieces of evidence indicate that I
 
 
 
B
 
  
 
is a master terminator
of the NF-
 
 
 
B response. First, it is rapidly resynthesized in
an NF-
 
 
 
B–dependent manner (8–10). Second, it can enter
the nucleus as a free, NF-
 
 
 
B–unbound protein (11). Finally,
it can export NF-
 
 
 
B from the nucleus (11–13). Therefore,
according to the current model of NF-
 
 
 
B response termi-
nation, after nuclear translocation, NF-
 
 
 
B remains stably
bound to target genes until resynthesized I
 
 
 
B
 
  
 
enters the
nucleus, dissociates it from DNA, and shuttles it back to the
cytoplasm, thus restoring the initial steady state. Analysis of
I
 
 
 
B
 
 
 
    
 
cells confirmed that resynthesis of I
 
 
 
B
 
  
 
provides a
strong negative feedback and a fast down-regulation of the
NF-
 
 
 
B response (14, 15), thus allowing the rapid termi-
nation of NF-
 
 
 
B activity after a transient TNF-
 
  
 
stimula-
tion. I
 
 
 
B
 
  
 
can fully compensate for I
 
 
 
B
 
  
 
deficiency when
knocked in the I
 
 
 
B
 
  
 
locus and placed under control of the
I
 
 
 
B
 
  
 
promoter, which indicates that the irreplaceable role
of I
 
 
 
B
 
  
 
in NF-
 
 
 
B response termination simply reflects its
unique temporal expression pattern (16). The main physio-
logical role of I
 
 
 
B
 
  
 
and I
 
 
 
B
 
 
 
, as deduced from computer
modeling applied to the analysis of gene-deficient cells, is
to prevent oscillations of the NF-
 
 
 
B response during long-
lasting activations (15). Additional roles of I
 
 
 
B
 
  
 
in nucleo-
cytoplasmic shuttling of NF-
 
 
 
B proteins cannot be ruled
out, although I
 
 
 
B
 
  
 
is markedly less efficient than I
 
 
 
B
 
  
 
in
this regard (17).
In addition to the global down-regulation of NF-
 
 
 
B ac-
tivity due to I
 
 
 
B
 
  
 
resynthesis, gene-specific mechanisms of
transcriptional shut-off exist that allow individual genes to
be regulated in a selective fashion and independently of the
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behavior of the bulk of nuclear NF-
 
 
 
B. These mechanisms
include the recruitment to target genes of NF-
 
 
 
B–induced
transcriptional repressors, such as Twist 1/2 (18), and the
replacement of an active NF-
 
 
 
B dimer with a dimer show-
ing no transcriptional activity in the context of that specific
gene (19).
The experiments described here were designed with the
aim of identifying additional mechanisms of NF-
 
 
 
B re-
sponse termination. We found that proteasome-dependent
degradation of nuclear p65/RelA is a major mechanism of
NF-
 
 
 
B response termination in the absence of I
 
 
 
B
 
 
 
. In
cells containing I
 
 
 
B
 
 
 
, proteasomal degradation of p65/
RelA provides an essential contribution to a prompt shut-
off of the response, thus indicating that proteasome and
I
 
 
 
B
 
  
 
synergistically act to efficiently and promptly termi-
nate transcription of NF-
 
 
 
B–dependent genes.
 
Materials and Methods
 
Antibodies and Reagents.
 
Anti-p65 (C20) was from Santa Cruz
Biotechnology, Inc., anti-I
 
 
 
B
 
  
 
monoclonal was from Imgenex,
anti-ubiquitin monoclonal antibody was from Zymed Laborato-
ries, and the anti-Sug1 antiserum was from Affinity BioReagents,
Inc. Anti-FLAG M2 was from Sigma-Aldrich. mTNF-
 
  
 
(R&D
Systems) was used at a final concentration of 10 ng/ml.
 
Plasmids.
 
Human p65 was cloned in frame with an NH
 
2
 
-ter-
minal FLAG epitope in a pCDNA3 (Invitrogen) derivative. The
 
 
 
B site binding-defective mutant of p65 was generated by mu-
tagenesis using the QuikChange kit (Stratagene) and tagged at the
NH
 
2 
 
terminus with either a FLAG or a green fluorescent protein
(GFP) tag. The myc ubiquitin expression vector was from R.
Kopito’s lab (Stanford University, Stanford, CA).
 
Detection of Ubiquitin Conjugates.
 
10 mM 
 
N
 
-ethylmaleimide
(NEM) dissolved in ethanol was added to the culture medium 30 s
before washing the cells in ice cold PBS containing 10 mM NEM.
Cells were lysed in RIPA buffer containing 20 mM NEM.
 
Chromatin Immunoprecipitation (ChIP) Assays.
 
ChIP assays
were performed as described previously (19). Sequences of pro-
moter-specific primers and a detailed protocol are available upon
request.
 
Results and Discussion
Proteasome-dependent Down-Regulation of the NF- B Re-
sponse in I B     Cells. To identify I B -independent
mechanisms of NF- B response termination, we analyzed
how the NF- B response is terminated in the absence of
I B . WT or I B     3T3 cells were stimulated with a
15-min pulse of TNF- , which induces the degradation of
the I Bs, and a single wave of nuclear translocation of p50/
p65, the most abundant NF- B dimer in fibroblasts. Cells
were then washed to remove TNF from the medium and
terminate signaling. They were then placed in normal me-
dium and returned to the incubator (Fig. 1 a). In agreement
with published results (14, 15), in WT 3T3 cells NF- B
activity was strongly down-regulated concurrently with
completion of I B  resynthesis, whereas in I B     3T3
cells the response was more sustained (Fig. 1 a). However,
in spite of I B  absence, in these cells nuclear NF- B lev-
els were also completely down-regulated in  4 h.
Figure 1. Termination of the NF-
 B response in I B -deficient cells.
(A) Kinetics of NF- B down-regu-
lation in WT and I B     3T3 cells.
Cells were stimulated with TNF- 
as indicated and analyzed for NF- B
binding activity by electrophoretic
mobility shift assay (EMSA) using a
canonical   B site as a probe (5 -
AGTTGAGGGGACTTTCCCA-
GGC-3 ). Data were quantified with
a phosphorimager. Kinetics of I B 
degradation and resynthesis are also
shown. (B) Proteasome inhibition
prevents NF- B down-regulation in
I B     cells. After TNF-   wash-
out, cells were incubated with   lac-
tone and assayed by EMSA. An anti-
p65 Western blot (W.B.) on cyto-
plasmic and nuclear extracts is
shown. (C) Endogenous p65 is
ubiquitinated after NF- B activa-
tion. Extracts from I B      cells
were immunoprecipitated with an
anti-p65 antibody and blotted with
an anti-ubiquitin monoclonal anti-
body. H.C., heavy chains. (D) Re-
constitution of p65 ubiquitination
by cotransfection of FLAG-p65 and myc-ubiquitin expression vectors in HEK-293T cells. Blots obtained from whole cell extracts were probed with an
anti-p65 polyclonal antibody and an anti-myc monoclonal antibody. (E) I B     cells were stimulated with TNF for 15 min, washed, and incubated
with 10 ng/ml LMB for an additional 3.15 h. EMSAs were performed on nuclear lysates. As a positive control for LMB effects, accumulation of I B kinase
complex   in the nuclear fraction of LMB-treated cells is shown.Saccani et al. Brief Deﬁnitive Report 109
When fused to the Gal4 DNA binding domain, the acti-
vation domains of p65 and of other TFs confer instability to
the chimeric protein (20). Instability depends on proteaso-
mal degradation of the fusion protein, which directly corre-
lates with the potency of the activation domain fused to
Gal4. Moreover, the domain(s) required for transcriptional
activity often overlaps with those triggering degradation
(21). Therefore, we tested if p65 is degraded by the protea-
some and if degradation may account for the decay of NF-
 B activity in I B     cells. I B     3T3 cells were stimu-
lated with TNF for 15 min, washed, and further incubated
with vehicle or clasto-lactacystin   lactone, a rapid and se-
lective inhibitor of the chymotryptic and tryptic-like activi-
ties of the proteasome. In the presence of   lactone, nearly
all nuclear NF- B activity and p65 protein were preserved
at  3 h after TNF washout (Fig. 1 b). Conversely, the cy-
toplasmic NF- B fraction did not show any obvious change
in abundance induced by proteasome inhibition.
To determine if p65 is a direct target of the proteasome,
we examined whether endogenous p65 is polyubiquitin-
ated. To this aim, p65 was immunoprecipitated from cells
stimulated as described above. A ladder of high molecular
weight forms of p65 was selectively recognized by a mono-
clonal antibody to ubiquitin in   lactone–treated cells (Fig.
1 c). To further demonstrate that p65 is polyubiquitinated,
we cotransfected HEK-293T cells with expression vectors
encoding p65 and myc-tagged ubiquitin. In these condi-
tions, p65 exceeds the endogenous I Bs and is constitu-
tively nuclear. High molecular weight forms of p65 were
strongly augmented by cotransfection of the ubiquitin ex-
pression vector (Fig. 1 d), thus demonstrating that p65 un-
dergoes polyubiquitination in vivo. Inhibition of Crm1-
dependent nuclear export by leptomycin B (LMB) after a
pulse of TNF only minimally interfered with complete
down-regulation of NF- B nuclear levels (Fig. 1 e), which
indicates that although a minor fraction of NF- B is prob-
ably exported in an I B -independent manner and de-
graded in the cytoplasm, most p65 molecules are in fact de-
graded in the nucleus.
These results indicate that if NF- B does not rapidly re-
associate with resynthesized I B , it is polyubiquitinated
and degraded by the proteasome. Assuming that  120,000
p65 molecules enter nucleus after stimulation (22), that
 3.5 h are required for their complete degradation, and
that the kinetics of degradation is linear, it can be roughly
estimated that  500–600 molecules of p65 are degraded
every minute.
p65 Ubiquitination Requires Sequence-specific Binding to  B
Sites. To investigate if sequence-specific DNA binding is
required for p65 polyubiquitination, we generated a p65
mutant in which two residues essential for base-specific
contacts, Tyr 23 and Glu 26 (corresponding to Tyr 36 and
Glu 39 in mouse p65; reference 23), were mutated to Ala
and Asp, respectively. The mutant p65 was virtually unable
to bind canonical  B sites, both in homodimers and in het-
erodimers with p50 (Fig. 2 a), whereas it was able to bind
p50 and I B  (Fig. 2 b). The different amount of I B 
immunoprecipitated by the WT and the mutant p65 likely
Figure 2. p65 ubiquitination requires sequence-specific
binding to  B sites. (A) WT p65 and a p65 mutant
bearing a double substitution in the Rel homology do-
main (23Y   A; 26E   D) were cloned with an NH2-
terminal GFP tag and transfected in HEK-293 cells
alone or with a p50 expression vector. Total lysates
were made and assayed by EMSA using a canonical  B
site as a probe. The GFP tag allows easy discrimination
between p65 homodimers and p65/p50 heterodimers
(n.s., nonspecific). An anti-p65 immunoblot shows the
expression of endogenous p65 and transfected GFP-
p65 in total lysates. Expression of I B  is also shown.
(B) Association of WT and mutant GFP-p65 with p50
and I B . 293T cells were transfected as indicated.
Total cell extracts were immunoprecipitated with either
an anti-p50 or an anti-I B  antibody and then blotted
with an anti-p65 antibody. (C) The  B site binding-
deficient p65 mutant is not efficiently polyubiqui-
tinated. HEK-293T were cotransfected with the indi-
cated expression vectors. Whole cell extracts were assayed
for the appearance of high molecular weight ubiqui-
tinated forms of p65 by anti-p65 immunoblotting. (D) p65
induces recruitment of proteasome components to target
genes. HEK-293 cells were transfected with empty
vector or a FLAG-p65 expression vector. ChIP assays
with an anti-FLAG antibody, an antibody against Sug1,
or a control antibody were performed. Recruitment of
FLAG-p65 and Sug1 to the endogenous I B  gene
promoter is shown. (E) Anti-p65 and anti-Sug1 ChIP
assays on HEK-293 cells stimulated with TNF- . Im-
munoprecipitated DNA was amplified with primers
spanning the I B  promoter or a region immediately
downstream of the I B  gene.Proteasomal Degradation of p65/RelA 110
reflects its different abundance in cells overexpressing either
of the two proteins. Indeed, although WT p65 increased
expression of endogenous I B , the mutant was devoid of
this activity (Fig. 2 a). The mutant p65 still retained a resid-
ual activity ( 15–20% of the WT protein) in luciferase as-
says (unpublished data). Polyubiquitination of the mutant
p65 was much lower than that of the normal protein (Fig.
2 c), which indicates that polyubiquitination of p65 mainly
occurs upon binding to specific target sites in the chroma-
tin. However, from these experiments it is not possible to
determine if p65 degradation is restricted to those mole-
cules actively engaged in transcriptional activation.
Recruitment of Proteasome Components to NF- B Target
Genes. If polyubiquitination and proteasome-dependent
degradation of p65 occur after recruitment to target genes,
then the proteasome itself should be recruited to NF-
 B–dependent promoters in a p65-dependent manner. To
test this possibility, we transfected HEK-293 cells with a
FLAG-p65 expression vector and performed a ChIP assay
with an antibody recognizing the S8 component (Sug1) of
the 19S proteasome complexes. p65 transfection induced a
large increase in the association of Sug1 to the I B  gene
promoter, a typical NF- B target (Fig. 2 d). Similarly,
TNF-  stimulation of HEK-293 cells induced Sug1 re-
cruitment to the I B  promoter, but not to a region
located immediately 3  of the I B  gene (Fig. 2 e), sug-
gesting that NF- B target genes may represent sites of pro-
teasome-dependent degradation of p65.
Removal of NF- B from Target Genes in I B     Cells Is
Proteasome Dependent. To determine if proteasomal degra-
dation of p65 is required to remove it from target genes,
we performed ChIP assays with an anti-p65 antibody. In
I B     3T3 cells, proteasome inhibition after a 15-min
TNF-  treatment caused the persistence of p65 on the pro-
moters of several validated p65 target genes (24), such as
the chemokines KC, inducible protein (IP)-10, and macro-
phage inflammatory protein (MIP)-2, as well as IL-6 (Fig. 3
a). mRNA levels for these and several other NF- B target
genes tested, with the exception of TNF- , were stronger
and more persistently up-regulated by TNF-   in cells
treated with   lactone than in cells where proteasome ac-
tivity is intact (Fig. 3 b).
To directly determine if proteasome activity is required
to shut off NF- B–dependent transcription in the absence
of I B , we transfected I B     3T3 cells with a luciferase
reporter controlled by three  B sites. After transfection,
cells were stimulated with TNF-  for 15 min, washed, and
incubated for an additional 6 h in medium with or without
Figure 3. Proteasome inhibition in
I B -deficient cells determines persistent
promoter occupancy and increased NF-
 B–dependent transcriptional activity.
(A) Anti-p65 ChIP in TNF- –stimu-
lated I B     cells.   lactone treatment
after a pulse of TNF prolongs occu-
pancy of all target genes tested and in-
duces (B) increased and sustained tran-
scription. (C) Proteasome inhibition
increases  B site–directed transcription
of a luciferase reporter in TNF- –stim-
ulated I B     cells.Saccani et al. Brief Deﬁnitive Report 111
  lactone.  B site–dependent transcription of the luciferase
gene was up-regulated much stronger in cells treated with
  lactone than in control cells (Fig. 3 c).
These observations indicate that in cells lacking I B ,
proteasomal degradation of p65 is required to remove it
from target genes and terminate the response. Persistent
promoter occupancy results in sustained NF- B–depen-
dent transcriptional activation.
p65 Degradation and NF- B Response Shut Off in I B -
containing Cells. Next, we tested if proteasome activity
also collaborates to NF- B response termination in cells
expressing I B . In WT 3T3 cells, proteasome inhibition
after a 15-min pulse of TNF-  prevented complete down-
regulation of nuclear NF- B activity (Fig. 4 a). This result
indicates that termination of the NF- B response in normal
cells reflects the combination of two separate activities: re-
synthesis of I B  and degradation of NF- B. In WT 3T3
cells,   lactone rescued  25% of maximal NF- B activity
(measured between 30 and 60 min after TNF- ).
To directly monitor if proteasome inhibition affects p65
occupancy of target gene promoters in normal cells, we
performed ChIP assays in WT 3T3 cells stimulated with a
pulse of TNF-  and then treated with   lactone.
Proteasome inhibition after NF- B activation impaired
or delayed the removal of p65 from the target genes MIP-2
and IP-10 (Fig. 4 b). The most obvious differences be-
tween control and   lactone–treated cells in p65 removal
from IP-10 were observed at the earlier time point (Fig. 4,
T2), whereas at MIP-2 the effect was more sustained.
Analysis of the corresponding mRNAs showed that al-
though MCP-1 was similarly induced and down-regulated
in control cells and cells treated with   lactone, MIP-2 and
IP-10 were induced in a more sustained fashion when pro-
teasome activity was blocked (Fig. 4 c). The lack of any de-
tectable effect on the accumulation of MCP-1 mRNA (a
p65 target itself) indicates that the effects of proteasome in-
hibition may in part be gene specific.
Overall, proteasome inhibition exerted more dramatic
effects in I B -deficient cells than in normal cells (Fig. 3
a), indicating a synergistic activity of proteasome and resyn-
thesized I B  in response termination. Indeed, in the ab-
sence of either I B  or proteasome activity, NF- B re-
sponse down-regulation was slower than normal.
The observation that proteasome inhibition impairs or
delays p65 removal from target genes even in the presence
of a normal I B  resynthesis is intriguing and may indi-
rectly provide additional mechanistic insights into how
NF- B is dissociated from chromatin. Several mechanisms
may plausibly explain why resynthesized I B  is unable to
promptly remove NF- B from some target genes if protea-
some is blocked. First, posttranslational modifications of
p65, such as acetylation (25) or prolyl isomerization (26),
have been shown to inhibit p65 interaction with I B . If a
promoter is loaded with p65 molecules bearing these mod-
ifications, it will likely depend on proteasomal degradation
for p65 removal unless the posttranslational modification is
erased. Second, when bound to some promoters in the
context of large complexes of TFs, NF- B might be not
accessible to I B . In this case, proteasome may either dis-
assemble and destroy the whole enhanceosome (including
p65) or indirectly facilitate I B  activity by removing pe-
ripherally located TFs, thus exposing DNA-bound p65.
In different cell types, in response to different stimuli,
and at the level of different promoters, the relative contri-
bution of the two pathways to response termination may
vary. Indeed, the behavior of NIH-3T3 and HeLa cells dif-
fered from that of WT 3T3 cells. In NIH-3T3 cells,   lac-
tone rescued  50% of the maximal NF- B binding activ-
ity (Fig. 4 d) and exerted a stronger and more sustained
effect on p65 occupancy of MIP-2 and IP-10 promoters
than that observed in WT 3T3 cells (Fig. 4 e). In HeLa
cells,   lactone partially impaired NF- B down-regulation
but only transiently, as response was anyway completely
terminated at late time points (unpublished data).
Conclusions. An adequate control of NF- B response
termination is of paramount importance to prevent a sus-
tained production of inflammatory mediators as well as an
extended transcription of the many other genes controlled
by the NF- B system. The absolute requirement for a
stringent control of NF- B activity is clearly indicated by
Figure 4. Effects of proteasome inhibition on
NF- B response termination in I B -containing
cells. (A) Proteasome inhibition impairs down-
regulation of nuclear NF- B activity (assayed
by EMSA) in WT 3T3 cells. I B  degradation
and resynthesis is also shown. (B) Anti-p65
ChIP assay and mRNA analysis (C) in TNF-
stimulated WT 3T3 cells treated with   lactone
or vehicle as indicated. The effects of   lactone
treatment on IP-10 and MIP-2 occupancy by
p65 and on their transcriptional activity are
shown. (D) Effects of proteasome inhibition on
NF- B response down-regulation and p65 occu-
pancy of target genes (E) in NIH3T3 cells.Proteasomal Degradation of p65/RelA 112
the multiple phenotypic abnormalities and the neonatal le-
thality observed in I B -deficient mice (14).
Here we show that p65 polyubiquitination and proteaso-
mal degradation is a dominant mechanism of posttranscrip-
tional repression in the absence of I B . More importantly,
this mechanism acts in synergism with resynthesized I B 
to guarantee a timely termination of the response in normal
cells. Because proteasome inhibition selectively affects the
nuclear fraction of p65, it is clear that degradation of p65 is
at least in great part linked to its activation. More specifi-
cally, p65 polyubiquitination requires binding to  B sites as
indicated by the inefficient ubiquitination of a p65 mutant
that is devoid of high affinity  B site binding activity.
Remarkably, the proteasome-dependent pathway of NF-
 B response termination is conserved from Drosophila to
mammals. Loss of function mutations in different compo-
nents of the Drosophila SCF-E3 ubiquitin ligases cause in-
creased levels of both full-length and processed Relish (a
Drosophila NF- B homologue) and constitutive induction
of the target gene diptericin (27).
The interplay between ubiquitin, proteasome, and tran-
scriptional regulation is extremely complex. A model com-
patible with many observations is that promoter-bound TFs
recruit ubiquitin ligases, which ubiquitinate both TFs and
RNApolI (28). Ubiquitination of TFs enhances their activ-
ity and promotes proteasome recruitment, which destroys
the TFs and at the same time may exert nonproteolytic ac-
tivities that stimulate transcription (29). As a consequence of
this mechanism, TFs recruited to target promoters would
trigger only a single round of transcriptional initiation and
would be subsequently destroyed and eventually reloaded.
In this context, the high number of p65-containing dimers
( 100,000) that enter the nucleus after activation may serve
as a reservoir of NF- B molecules available for the repeti-
tion of the cycle of recruitment, transcriptional activation,
and degradation. The evaluation of the possible role of p65
ubiquitination in transcriptional activation will require the
identification of the p65 ubiquitin ligase(s) acting at the pro-
moter level. SOCS-1 has been recently reported to poly-
ubiquitinate p65 and promote its degradation (26), but be-
cause SOCS-1 is mainly cytoplasmic it is unlikely to act in a
transcription-coupled ubiquitination/degradation pathway.
In addition to its role in response termination, degrada-
tion of chromatin-bound NF- B molecules may also pro-
mote an exchange of NF- B dimers at target genes (19),
thus indirectly impacting on their transcriptional activity.
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